Outpatient management of community-acquired pneumonia

Recently published guidelines permit the decision to treat patients with community-acquired pneumonia on an outpatient basis to be made more confidently than in the past. In most cases, the risk of 30-day mortality can be evaluated without extensive laboratory testing. Antibiotic therapy with erythromycin or doxycycline is generally effective.